Read more about GSK says it aims to bring FDA-approved antibody therapy to India for Covid on Business Standard. Treatment with Sotrovimab resulted in an 85 per cent reduction in the risk of hospitalization, says company.
Subscription Notification
We have noticed that there is an issue with your subscription billing details. Please update your billing details here
Please update your billing information
The subscription details associated with this account need to be updated. Please update your billing details here to continue enjoying your subscription.
Your subscription will end shortly
Please update your billing details here to continue enjoying your access to the most informative and considered journalism in the UK.
EEUU autoriza un fármaco contra el COVID-19 que reduce 85% las posibilidades de internación y muerte primerafuente.com.ar - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from primerafuente.com.ar Daily Mail and Mail on Sunday newspapers.
GSK moves into the vaccine race
GlaxoSmithKline says it can backtrack on the Covid-19 vaccine and play an important role in preparing new pandemics after testing positive data.
The vaccine maker is talking to internal governments in the UK about creating vaccine manufacturing facilities in their homes, and is investing heavily in mRNA, behind the successful plans of BioNTech / Pfizer and Moderna.
GSK has not helped last year to any generation of Covid-19 vaccines his French partner Sanofi it had to be repeated due to a dosing error. The company decided to provide an assistant that promotes the effectiveness of many vaccines to several partners, rather than developing its own shot.